Similar Papers

Paper Title
Journal
Date
Author
Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response
Peter Ferenci ... Petra Steindl–Munda
Gastroenterology | VOL. 135
Peter Ferenci, et. al.Peter Ferenci ... Petra Steindl–Munda
17 Apr 2008
Optimizing Outcomes in Hepatitis C: Is Treatment Beyond 48 Weeks Ever Justified?
Robert J Fontana
Gastroenterology | VOL. 130
Robert J FontanaRobert J Fontana
01 Apr 2006
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Christian M Lange ... Stefan Zeuzem
Journal of Hepatology | VOL. 55
Christian M Lange, et. al.Christian M Lange ... Stefan Zeuzem
25 Mar 2011
Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection
-
Journal of Gastroenterology and Hepatology | VOL. 22
--
18 Apr 2007
View more papers

More From: Clinical and Molecular Hepatology

Paper Title
Journal
Date
Author
Revealing the Importance of a Multidisciplinary Approach to Reducing the Global Burden of SLD Through the COVID-19 Pandemic: Editorial on "Current Burden of Steatotic Liver Disease and Fibrosis among Adults in the United States, 2017-2023".
Jeayeon Park ... Su Jong Yu
Clinical and molecular hepatology | VOL. -
Jeayeon Park, et. al.Jeayeon Park ... Su Jong Yu
16 Jan 2025
Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".
Yoon-Su Ha ... Seung-Jin Kim
Clinical and molecular hepatology | VOL. -
Yoon-Su Ha, et. al.Yoon-Su Ha ... Seung-Jin Kim
16 Jan 2025
Targeting TM4SF1 to overcome immunotherapy resistance in hepatocellular carcinoma.
Valerie Chew
Clinical and molecular hepatology | VOL. -
Valerie ChewValerie Chew
16 Jan 2025
Reply to correspondence on "Circulating cell-free mitochondrial DNA for diagnosing hepatocellular carcinoma and assessing prognosis".
Hyuk Soo Eun
Clinical and molecular hepatology | VOL. -
Hyuk Soo EunHyuk Soo Eun
16 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.